FOXNEWS Americas Newsroom June 4, 2024 15:31:00
The fda approved the new drug. they claim only, though, it quote may modestly slow the pace of doing anytive decline early on in the disease. fda is acknowledging it has major risks for patients. the manufacturer says, quote, accelerated approval of the drug was based on phase two data. here is where things get controversial. the fda acknowledges the drug exposes patients to the risk of brain swelling and brain bleeding. in a recent congressional investigation issued a scathing finding when it came to the fda's rushed approval process for another demeanings yeah drug. it accuses biogen of coll...